Mohammad Taghi Rahimi

Mohammad Taghi Rahimi

Auto-generated profile, based on publicly available information

Mohammad Taghi Rahimi

School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Acta Tropica
Verified
Journal Article
Closed access
ADAhmad Daryani
Ahmad Daryani
SSShahabeddin Sarvi
Shahabeddin Sarvi
MAMohsen Aarabi
Mohsen Aarabi
AMAzadeh Mizani
Azadeh Mizani
Ehsan AhmadpourEhsan Ahmadpour
Ehsan Ahmadpour
MSMehdi Sharif
Mehdi Sharif

14 December 2014 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
Ehsan AhmadpourEhsan Ahmadpour
Ehsan Ahmadpour
ADAhmad Daryani
Ahmad Daryani
MSMahdi Sharif
Mahdi Sharif
SSShahabeddin Sarvi
Shahabeddin Sarvi
MAMohsen Aarabi
Mohsen Aarabi
HWHaochang Wang
Haochang Wang
Although toxoplasmosis in immunocompetent individuals is generally asymptomatic, in immunocompromised patients (HIV/AIDS, cancer, and transplant patients), it can lead to serious pathological effects. This study included a systematic review and meta-analysis to comprehensively assess the seroprevalence rate of Toxoplasma infection in immunocompromised patients in Iran. Electronic English and Persian databases (PubMed, Google Scholar, ScienceDirect, Scopus, Magiran, Scientific Information Database [SID], IranMedex, and IranDoc), parasitology congresses, and projects and theses of Iranian medical universities, were systematically searched from 1997 to 2013 (published or unpublished data). In this paper, several studies that used serological methods for diagnosis of toxoplasmosis were selected. Analysis of seroprevalence estimates was pooled using a random-effects meta-analysis. Twenty-two studies, comprising 2,805 individuals, were included in the meta-analysis. Overall seroprevalence rate of Toxoplasma infection in Iranian immunocompromised patients was 50.01% (95% confidence interval, 43.85 to 56.17); however, there was significant heterogeneity among study groups. The results showed that seroprevalence rate of toxoplasmosis among transplant recipients, HIV/AIDS, and cancer patients in Iran was 55.1%, 50.05%, and 45.06%, respectively. In addition, IgM seroprevalence rate was estimated to be 4.85% (95% confidence interval, 2.22 to 8.41). This systematic review and meta-analysis identified a high seroprevalence rate of Toxoplasma infection among immunocompromised patients (50%).Consideration of management , design and provision of appropriate control measures of toxoplasmosis is highly recommended.

15 February 2016 in Mycoses
Verified
Journal Article
Closed access
PDF file
AVAfsane Vaezi
Afsane Vaezi
MMMaryam Moazeni
Maryam Moazeni
MRMohammad Taghi Rahimi
Mohammad Taghi Rahimi
SHSybren de Hoog
Sybren de Hoog
Hamid BadaliHamid Badali
Hamid Badali

4 January 2017 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
Hamed BarabadiHamed Barabadi
Hamed Barabadi
SHSoheila Honary
Soheila Honary
MMMilad Ali Mohammadi
Milad Ali Mohammadi
Ehsan AhmadpourEhsan Ahmadpour
Ehsan Ahmadpour
MRMohammad Taghi Rahimi
Mohammad Taghi Rahimi
Saravanan MuthupandianSaravanan Muthupandian
Saravanan Muthupandian

1 July 2015 in International Journal of Surgery
Verified
Journal Article
Closed access
MRMohammad Taghi Rahimi
Mohammad Taghi Rahimi
Ehsan AhmadpourEhsan Ahmadpour
Ehsan Ahmadpour
BEBahman Rahimi Esboei
Bahman Rahimi Esboei
ASAdel Spotin
Adel Spotin
MKMohammad Hasan Kohansal
Mohammad Hasan Kohansal
MMMilad Ali Mohammadi
Milad Ali Mohammadi
Cystic hydatid disease (CHD), a helminth infection with various clinical complications caused by the larval stage of the dog tapeworm Echinococcus granulosus is considered as a public health problem in different regions of the world. To date, scolicidal agents have been broadly applied for inactivation of the fertile cysts and these scolicidal agents have several side effects on patients. Therefore, the objective of this study was to evaluate the scolicidal efficacies of synthesized silver nanoparticles (AgNPs) derived from the aqueous aerial extract of Penicillium aculeatum against protoscolices of CHD in-vitro. Protoscolices were aseptically aspirated from infected livers of sheep with CHD. Various concentrations (0.025, 0.05, 0.1 and 0.15 mg/mL) of green synthesis of Ag-NPs and different exposure times (10, 30, 60 and 120 min) were used against protoscolices of CHD. Viability of protoscolices was confirmed by 0.1% eosin staining. The findings showed that the Ag-NPs at all concentrations have high scolicidal effects. The concentrations 0.1 and 0.15 mg/mL after 120 min of exposure times showed 83% and 90% mortality rate, respectively. The least scolicidal activity of biosynthesized Ag-NPs was 40% (0.025 mg/mL and 10 min). The current investigation indicated that applying biogenic Ag-NPs may be considered as a potential scolicidal agent for CHD surgery due to being economical, safer and non-toxic compared to the used chemical materials. However, further studies are required to evaluate the efficacy of Ag-NPs in vivo.

8 November 2014 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
MSM. Sharif
M. Sharif
SSSh. Sarvi
Sh. Sarvi
HWHaochang Wang
Haochang Wang
STSaeed Hosseini Teshnizi
Saeed Hosseini Teshnizi
MRM. T. Rahimi
M. T. Rahimi
ADAhmad Daryani
Ahmad Daryani